New: The Perimenopause Report — what's normal, what isn't, and what actually helps. Get it free →
Media request

Book Dr. Hoffman for your interview or podcast

A high-risk pregnancy specialist, researcher and Professor at the University of Colorado School of Medicine who explains complicated medicine in plain language, for journalists, producers and podcast hosts.

Dr. Camille Hoffman, smiling, in a white coat
  • Double board certifiedObstetrics & Gynecology and Maternal-Fetal Medicine
  • 75+ peer-reviewed publicationsPrenatal choline, perinatal mental health, high-risk pregnancy
  • ACOG guideline co-authorThe first clinical practice guidelines on perinatal mental health
  • Integrative Medicine fellowshipUniversity of Arizona Center for Integrative Medicine
Topics

What Dr. Hoffman speaks about

Each topic is grounded in her clinical work and research, and framed around the questions your audience is already asking: Why is this happening? How worried should I be? What happens next?

Preconception

Getting ready for pregnancy

What to do in the months before trying to conceive, which questions matter most, and how preparation shapes a healthier pregnancy for mother and baby.

High-risk pregnancy

What the label really means

A maternal-fetal medicine specialist on what makes a pregnancy "high-risk," how worried families should be, and what happens next. She oversees training and the fellowship program for maternal-fetal medicine at the University of Colorado.

Postpartum depression & mental health

Mind and body, together

Depression and anxiety in pregnancy and after birth, why maternal mental health is a major contributor to maternal mortality, and the obstetrician's role in care. She co-authored ACOG's first clinical practice guidelines on perinatal mental health and served on its expert working group.

Research: choline

Choline and the baby's brain

Her randomized trial of choline supplementation in pregnancy, an NIH-funded trial on protecting early brain development, and why this nutrient matters. Named a Brain & Behavior Research Foundation 2020 Leading Research Achievement.

Research: psychedelics

New research in postpartum depression

Dr. Hoffman is principal investigator for the CU Anschutz study site of a national clinical trial of RE104, an investigational psilocybin-like compound for postpartum depression, which she presented at the Society for Maternal-Fetal Medicine annual meeting (2025). She can speak to the science and where the research stands.

This is research only. RE104 is investigational, is not an approved treatment, and is not offered through Dr. Hoffman or this website.

Short bio

For show notes and introductions

Camille Hoffman, MD, MSCS is a Professor of Obstetrics and Gynecology (Maternal-Fetal Medicine) at the University of Colorado School of Medicine, with a secondary appointment in Psychiatry. She is double board-certified in Obstetrics and Gynecology and Maternal-Fetal Medicine and fellowship-trained in Integrative Medicine. Her research on prenatal choline and perinatal mental health has produced more than 75 peer-reviewed publications, and she co-authored ACOG's first clinical practice guidelines on perinatal mental health.

In the news

Recent coverage

Coverage of postpartum depression research describes an investigational treatment. It is not a treatment offered by Dr. Hoffman or through this website.

Booking

Request an interview

Tell us about your outlet and audience and the topics you'd like Dr. Hoffman to cover. We'll reply by email.

Prefer email? Write to media@camillehoffmanmd.com. It helps to include the format (live, recorded, print or video), your deadline or recording date, and the expected length.

This form and address are for media and speaking requests only. Dr. Hoffman can't answer personal medical questions or arrange care this way; please contact your own healthcare provider. Interviews reflect Dr. Hoffman's independent work, separate from her affiliation with the University of Colorado.

Topics you'd like Dr. Hoffman to discuss

Notes from Dr. Hoffman

A thoughtful email every other week. Unsubscribe anytime. Privacy